Home - Products - Endocrinology/Hormones - 5-HT Receptor - PNU 22394 hydrochloride

PNU 22394 hydrochloride

CAS No. 15923-42-9

PNU 22394 hydrochloride( —— )

Catalog No. M23693 CAS No. 15923-42-9

PNU 22394 hydrochloride is a 5-HT2C agonist and partial 5-HT2A/5-HT2B agonist.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	93	In Stock
10MG	143	In Stock
25MG	257	In Stock
50MG	369	In Stock
100MG	528	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

PNU 22394 hydrochloride
Note

Research use only, not for human use.
Brief Description

PNU 22394 hydrochloride is a 5-HT2C agonist and partial 5-HT2A/5-HT2B agonist.
Description

PNU 22394 hydrochloride is a 5-HT2C agonist and partial 5-HT2A/5-HT2B agonist.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Endocrinology/Hormones
Target

5-HT Receptor
Recptor

5-HT2C|partial 5-HT2A/5-HT2B
Research Area

——
Indication

——

Chemical Information

CAS Number

15923-42-9
Formula Weight

236.74
Molecular Formula

C13H17ClN2
Purity

>98% (HPLC)
Solubility

H2O:23mg/ml(97.15mM; need ultrasonic)
SMILES

CN1C(CCNCC2)=C2C3=C1C=CC=C3.[H]Cl
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Peptide 401

Peptide 401 is an antimicrobial peptide (AMP) derived from the venom of bees and wasps. Peptide 401 induces mast cell degranulation, activating histamine release from peritoneal mast cells. Additionally, peptide 401 exhibits some anti-inflammatory activity, decreasing paw edema in animal models.
Doxepin hydrochlorid...

Doxepin HCl is a tricyclic antidepressant that is marketed worldwide.
Cerlapirdine

Cerlapirdine is a selective, potent, full antagonist of the 5-hydroxytryptamine 6 (5-HT6) receptor. Cerlapirdine is already in clinical development for the treatment of cognitive disorders related to Alzheimer's disease and schizophrenia. It works by acting as a selective 5-HT6 receptor antagonist.

Sign In Join Free